Antidote treatment - nerve AG

Active Awarded

Contract number
SPE2DP26F7931
Awardee
Awarding agency
Obligated
$20,058,500

Award facts

Contract value 100% obligated
$20,058,500.00 Current and potential, with all options
Completion date 35% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Available for Competition Only One Source
Pricing
Firm Fixed Price
Place of performance
St. Louis, MO 63146, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency Medical Supply Chain issued a $20.1 million delivery order to Meridian Medical Technologies, LLC on July 22, 2026, for antidote treatment—nerve agent supplies through April 23, 2027.

The order is issued under Meridian's single-award IDC with DLA Medical Supply Chain, a $226.44 million vehicle established December 5, 2025, through December 4, 2028, supporting nerve agent antidote supply chain operations. Place of performance is St. Louis, MO. The delivery order carries firm fixed price pricing and covers no set-aside.

Quick answers

Who was awarded contract SPE2DP26F7931?

SPE2DP26F7931 was awarded to Meridian Medical Technologies, LLC by Medical Supply Chain (Troop Support) on July 22, 2026.

How much is contract SPE2DP26F7931 worth?

The government has obligated $20,058,500 on SPE2DP26F7931.

Is contract SPE2DP26F7931 an order under another contract?

Yes. SPE2DP26F7931 is a delivery order under SPE2DP26D0001, an indefinite delivery contract.

Was contract SPE2DP26F7931 competed?

The extent of competition for SPE2DP26F7931 was not available for competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award